Charlotte Breuillard

Charlotte Breuillard

Auto-generated profile, based on publicly available information

Charlotte Breuillard

Université Grenoble Alpes, Inserm

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2015 in Amino Acids
Verified
Journal Article
Closed access
PDF file
CBC. Breuillard
C. Breuillard
LCL. Cynober
L. Cynober
CMC. Moinard
C. Moinard

30 October 2023 in Frontiers in Nutrition
Verified
Journal Article
Open access
CBCharlotte Breuillard
Charlotte Breuillard
SMSophie Moulin
Sophie Moulin
SBSophie Bouyon
Sophie Bouyon
MCMorgane Couchet
Morgane Couchet
CMChristophe Moinard
Christophe Moinard
EBElise Belaidi
Elise Belaidi
Obstructive sleep apnea syndrome (OSAS) is associated with chronic intermittent hypoxia (cIH) that causes disturbances in glucose and lipid metabolism. Animals exposed to cIH show lower body weight and food intake, but the protein-energy metabolism has never been investigated. Here, to address the gap, we studied the impact of cIH on nutritional status in rats. A total of 24 male Wistar rats were randomized into 3 groups (n = 8): a control group (Ctrl), a cIH group (cIH) exposed to cIH (30 s 21–30 s 5% fraction of inspired oxygen, 8 h per day, for 14 days), and a pair-fed group (PF) exposed to normoxia with food intake adjusted to the intake of the cIH group rats with anorexia. Body weight and food intake were measured throughout the study. After 14 days, the rats were euthanized, the organs were collected, weighed, and the liver, intestine mucosa, and muscles were snap-frozen to measure total protein content. Food intake was decreased in the cIH group. Body weight was significantly lower in the cIH group only (−11%, p < 0.05). Thymus and liver weight as well as EDL protein content tended to be lower in the cIH group than in the Ctrl and PF groups. Jejunum and ileum mucosa protein contents were lower in the cIH group compared to the PF group. cIH causes a slight impairment of nutritional status and immunity. This pre-clinical work argues for greater consideration of malnutrition in care for OSAS patients. Further studies are warranted to devise an adequate nutritional strategy.

4 September 2023 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
MBMartin Boutière
Martin Boutière
CCCécile Cottet‐Rousselle
Cécile Cottet‐Rousselle
CCCéline Coppard
Céline Coppard
KCKarine Couturier
Karine Couturier
CFCatherine Féart
Catherine Féart
CBCharlotte Breuillard
Charlotte Breuillard
Background: Combating malnutrition and cachexia is a core challenge in oncology. To limit muscle mass loss, the use of proteins in cancer is encouraged by experts in the field, but it is still debated due to their antagonist effects. Indeed, a high protein intake could preserve lean body mass but may promote tumour growth, whereas a low‐protein diet could reduce tumour size but without addressing cachexia. Here we used a realistic rodent model of cancer and chemotherapy to evaluate the influence of different protein intakes on cachexia, tumour response to chemotherapy and immune system response. The goal is to gain a closer understanding of the effect of protein intake in cancer patients undergoing chemotherapy.Methods: Female Fischer 344 rats were divided into six groups: five groups (n = 14 per group) with cancer (Ward colon tumour) and chemotherapy were fed with isocaloric diets with 8%, 12%, 16%, 24% or 32% of caloric intake from protein and one healthy control group (n = 8) fed a 16% protein diet, considered as a standard diet. Chemotherapy included two cycles, 1 week apart, each consisting of an injection of CPT‐11 (50 mg/kg) followed by 5‐fluorouracil (50 mg/kg) the day after. Food intake, body weight, and tumour size were measured daily. On day 9, the rats were euthanized and organs were weighed. Body composition was determined and protein content and protein synthesis (SUnSET method) were measured in the muscle, liver, intestine, and tumour. Immune function was explored by flow cytometry.Results: Cancer and chemotherapy led to a decrease in body weight characterized by a decrease of both fat mass (−56 ± 3%, P < 0.05) and fat‐free mass (−8 ± 1%, P < 0.05). Surprisingly, there was no effect of protein diet on body composition, muscle or tumour parameters (weight, protein content, or protein synthesis) but a high cumulative protein intake was positively associated with a high relative body weight and high fat‐free mass. The immune system was impacted by cancer and chemotherapy but not by the different amount of protein intake.Conclusions: Using a realistic model of cancer and chemotherapy, we demonstrated for the first time that protein intake did not positively or negatively modulate tumour growth. Moreover, our results suggested that a high cumulative protein intake was able to improve moderately nutritional status in chemotherapy treated cancer rodents. Although this work cannot be evaluated clinically for ethical reasons, it nevertheless brings an essential contribution to nutrition management for cancer patients.

1 August 2012 in Critical Care Medicine
Verified
Journal Article
Closed access
CBCharlotte Msc Breuillard
Charlotte Msc Breuillard
SDSylviane Darquy
Sylviane Darquy
ECEmmanuel Curis
Emmanuel Curis
NNNathalie Neveux
Nathalie Neveux
JGJean-Pierre Garnier
Jean-Pierre Garnier
Jean Pascal De BandtJean Pascal De Bandt
Jean Pascal De Bandt
Objective: Obese and type 2 diabetic patients present metabolic disturbance–related alterations in nonspecific immunity, to which the decrease in their plasma arginine contributes. Although diabetes-specific formulas have been developed, they have never been tested in the context of an acute infectious situation as can be seen in intensive care unit patients. Our aim was to investigate the effects of a diabetes-specific diet enriched or not with arginine in a model of infectious stress in a diabetes and obesity situation. As a large intake of arginine may be deleterious, this amino acid was given in graded fashion. Design: Randomized, controlled experimental study. Setting: University research laboratory. Subjects: Zucker diabetic fatty rats. Interventions: Gastrostomized Zucker diabetic fatty rats were submitted to intraperitoneal lipopolysaccharide administration and fed for 7 days with either a diabetes-specific enteral nutrition without (G group, n = 7) or with graded arginine supply (1–5 g/kg/day) (GA group, n = 7) or a standard enteral nutrition (HP group, n = 10). Measurements and Main Results: Survival rate was better in G and GA groups than in the HP group. On day 7, plasma insulin to glucose ratio tended to be lower in the same G and GA groups. Macrophage tumor necrosis factor-α (G: 5.0 ± 1.1 ng/2 × 106 cells·hr−1; GA: 3.7 ± 0.8 ng/2 × 106 cells·hr−1; and HP: 1.7 ± 0.6 ng/2 × 106 cells·hr−1; p < .05 G vs. HP) and nitric oxide (G: 4.5 ± 1.1 ng/2 × 106 cells·hr−1; GA: 5.1 ± 1.0 ng/2 × 106 cells·hr−1; and HP: 1.0 ± 0.5 nmol/2 × 106 cells·hr−1; p < .05 G and GA vs. HP) productions were higher in the G and GA groups compared to the HP group. Macrophages from the G and GA groups exhibited increased arginine consumption. Conclusions: In diabetic obese and endotoxemic rats, a diabetes-specific formula leads to a lower mortality, a decreased insulin resistance, and an improvement in peritoneal macrophage function. Arginine supplementation has no additional effect. These data support the use of such disease-specific diets in critically ill diabetic and obese patients.

1 February 2017 in Biochimie
Verified
Journal Article
Closed access
CBCharlotte Breuillard
Charlotte Breuillard
ECEmmanuel Curis
Emmanuel Curis
SPServane Le Plénier
Servane Le Plénier
LCLuc Cynober
Luc Cynober
CMChristophe Moinard
Christophe Moinard

1 July 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
CBC. Breuillard
C. Breuillard
CMChristophe Moinard
Christophe Moinard
AGA. Goron
A. Goron
NNN. Neveux
N. Neveux
ARAntoine de Reviers
Antoine de Reviers
Vickie Elaine BaracosVickie Elaine Baracos
Vickie Elaine Baracos